| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/06/2014 | US20140037623 Pharmaceutical Compositions Comprising Antibodies Binding To EBV (Ebstein-Barr Virus) Protein BARF1 |
| 02/06/2014 | US20140037621 Antibodies or fusion proteins multimerized via cysteine mutation and a mu tailpiece |
| 02/06/2014 | US20140037619 Mimotopes of hiv env |
| 02/06/2014 | US20140037616 Immunoglobulin 1 |
| 02/06/2014 | US20140037551 Antibodies to human b7x for treatment of metastatic cancer |
| 02/06/2014 | US20140037540 Compositions against cancer antigen liv-1 and uses thereof |
| 02/05/2014 | EP2692861A1 Nucleic acid construct containing nucleic acid derived from genotype 1b hcv genome, hcv genome-replicating cells transfected with same, and method for producing infectious hcv particles |
| 02/05/2014 | EP2692737A1 Fully human anti-vap-1 monoclonal antibodies |
| 02/05/2014 | EP2692736A1 BSA-specific antibodies |
| 02/05/2014 | EP2692735A1 Antibody reacting with native cochlin-tomoprotein (ctp) and method for measuring ctp using same |
| 02/05/2014 | EP2692733A1 Nucleic acids encoding soluble forms of CD83 |
| 02/05/2014 | EP2692358A1 Therapeutic agent for cancer, and method for determining prognosis of cancer |
| 02/05/2014 | EP2692357A1 Novel anti-plasmodium parasite antibodies |
| 02/05/2014 | EP2692354A1 Means for treating heart disease |
| 02/05/2014 | EP2691421A1 Antibodies against kidney associated antigen 1 and antigen binding fragments thereof |
| 02/05/2014 | EP2691420A1 Modulators of plexin b2 activity |
| 02/05/2014 | EP2691419A2 Antibodies directed against icos and uses thereof |
| 02/05/2014 | EP2691418A1 Bispecific anti-cxcr7 immunoglobulin single variable domains |
| 02/05/2014 | EP2691417A1 Antibody fc variants |
| 02/05/2014 | EP2691416A1 Dual variable region antibody-like binding proteins having cross-over binding region orientation |
| 02/05/2014 | EP2691415A1 Method for producing solid formulations comprising immunoglobulin single variable domains |
| 02/05/2014 | EP2691156A1 Anticoagulant antidotes |
| 02/05/2014 | EP2691113A1 Methods of administering beta7 integrin antagonists |
| 02/05/2014 | CN103562389A A novel expression cassette for efficient surface display of antigenic proteins |
| 02/05/2014 | CN103562227A Pcsk9拮抗剂 Pcsk9 antagonist |
| 02/05/2014 | CN103562226A Use of inhibitors of EGFR-family receptors in the treatment of hormone refractory breast cancers |
| 02/05/2014 | CN103562225A BCMA (CD269/TNFRSF17) binding proteins |
| 02/05/2014 | CN103562224A Antibodies against human IL33R and uses thereof |
| 02/05/2014 | CN103562223A Anti c-Met antibodies |
| 02/05/2014 | CN103562222A Bispecific binding molecules binding to VEGF and Ang2 |
| 02/05/2014 | CN103562221A Dual variable region antibody-like binding proteins having cross-over binding region orientation |
| 02/05/2014 | CN103555732A Preparation method and application of aspergillus flavus specific single-chain antibody |
| 02/05/2014 | CN103555668A Hybridoma cell strain and anti-Wnt5a monoclonal antibody produced thereby as well as application thereof |
| 02/05/2014 | CN103554264A Bispecific antibody aiming at IL-1beta and IL-17A and application thereof |
| 02/05/2014 | CN103554263A Apoptotic anti- IgE antibodies binding the membrane-bound IgE |
| 02/05/2014 | CN103554262A Anti-cyclooxygenase humanized single-chain antibody |
| 02/05/2014 | CN103554261A A CA6 antigen-specific cytotoxic conjugate and methods of using the same |
| 02/05/2014 | CN103554260A Generation and profiling of fully human hucal gold-derived therapeutic antibodies specific for human cd38 |
| 02/05/2014 | CN103554259A Generation and profiling of human derived therapeutic antibodies specific for human cd38 |
| 02/05/2014 | CN103554258A Binding members for interleukin-6 |
| 02/05/2014 | CN103554257A Anti-schistosoma japonicum Sjp40 chicken egg-yolk antibodies, and preparation method and application thereof |
| 02/05/2014 | CN103554256A Anti-human glycated albumin monoclonal antibody and use thereof |
| 02/05/2014 | CN103554255A Monoclonal antibody for resisting chlamys farreri C-type agglutinin recombination protein and preparation method thereof |
| 02/05/2014 | CN103554254A Chicken egg yolk antibody resisting human A rotavirus as well as preparation method and application thereof |
| 02/05/2014 | CN103554253A Preparation method for human immunoglobulin for intravenous injection |
| 02/05/2014 | CN103554252A Giant cell human immunoglobulin and preparation method thereof |
| 02/05/2014 | CN103554251A Simple method for extracting egg yolk antibodies |
| 02/05/2014 | CN103554249A Complete antigen of AG15 polypeptide as well as preparation method and antibody thereof |
| 02/05/2014 | CN103554235A RBD (receptor binding domain) segment in MERS-CoV (Middle East respiratory syndrome coronavirus) membrane protein and coding gene and application thereof |
| 02/05/2014 | CN103554234A Competitive ELISA method based on foot-and-mouth disease A type VP1 protein and its monoclonal antibody |
| 02/05/2014 | CN103554233A Duck plague virus (DPV) UL13 intercepted recombinant protein and polyclonal antibody, preparation method and application thereof |
| 02/05/2014 | CN103554227A Polypeptide and use thereof |
| 02/05/2014 | CN103554215A Antibody purification by cation exchange chromatography |
| 02/05/2014 | CN103554056A Hapten, artificial antigen and monoclonal antibody for phenothiazine medicaments, preparation methods of hapten and artificial antigen and application of monoclonal antibody |
| 02/05/2014 | CN103550790A Applications of Periostin gene and Periostin antibody in preparation of medicaments |
| 02/05/2014 | CN102206663B Nucleic acid construct containing full-length genome of human hepatitis C virus and uses |
| 02/04/2014 | US8642745 Method for making multispecific antibodies having heteromultimeric and common components |
| 02/04/2014 | US8642742 Anti-CEA antibodies |
| 02/04/2014 | US8642740 Antibodies to lymphotoxin-alpha |
| 02/04/2014 | US8642737 Nucleophilic catalysts for oxime linkage |
| 02/04/2014 | US8642725 Process for production of peptide thioester |
| 02/04/2014 | US8642546 FGF21 mutant fusion polypeptides and uses thereof |
| 02/04/2014 | US8642536 Method of making biologically active alpha-beta peptides |
| 02/04/2014 | US8642534 Proteins and polynucleotides of Vibrio cholerae |
| 02/04/2014 | US8642513 Method for preparing immunoglobulin libraries |
| 02/04/2014 | US8642512 Method of detecting early immune activation |
| 02/04/2014 | US8642330 Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility |
| 02/04/2014 | US8642277 Tumor microenvironment of metastasis (TMEM) and uses thereof in diagnosis, prognosis and treatment of tumors |
| 02/04/2014 | US8642276 Method for the production of an immunostimulating mucin (MUC1) |
| 02/04/2014 | US8642050 Gonococcal proteins and nucleic acids |
| 02/04/2014 | US8642044 Prevention and treatment of amyloidogenic disease |
| 02/04/2014 | US8642039 Method of treating a staphylococcus infection in a patient having a low-level pathogenic Pseudomonas aeruginosa infection |
| 02/04/2014 | US8642037 Antibodies to insulin-like growth factor I receptor |
| 02/04/2014 | US8642036 Treatment with anti-ErbB2 antibodies |
| 02/04/2014 | US8642035 Anti-TrkB antibodies |
| 02/04/2014 | US8642034 Use of TGF-β antagonists to treat infants at risk of developing bronchopulmonary dysplasia |
| 02/04/2014 | CA2606250C Monoclonal antibodies and methods for their use in the detection of cervical disease |
| 02/04/2014 | CA2548180C Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells |
| 02/04/2014 | CA2547655C Novel centromeric protein shugoshin |
| 02/04/2014 | CA2539273C A fusion protein comprising an interleukin-1 receptor antagonist and uses thereof |
| 02/04/2014 | CA2507055C Treatment of prion-induced diseases by administration of anti-prion antibodies |
| 02/04/2014 | CA2498008C Novel composition and methods for the treatment of immune related diseases |
| 02/04/2014 | CA2453470C Use of follistatin for the treatment of hepatic fibrogenesis |
| 02/04/2014 | CA2442533C A simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome or polyplex for systemic administration of a therapeutic or diagnostic agent |
| 02/04/2014 | CA2326388C A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof |
| 02/04/2014 | CA2274801C Mammalian cell surface antigens; related reagents |
| 01/30/2014 | WO2014018926A1 Methods and compositions for determining resistance to androgen receptor therapy |
| 01/30/2014 | WO2014018841A1 Methods of treating fgfr3 related conditions |
| 01/30/2014 | WO2014018625A1 Anti-kit antibodies and uses thereof |
| 01/30/2014 | WO2014018620A1 Methods and compounds for reducing threonyl-trna synthetase activity |
| 01/30/2014 | WO2014018572A2 Immunoglobulin constructs comprising selective pairing of the light and heavy chains |
| 01/30/2014 | WO2014018554A1 Ptprs and proteoglycans in autoimmune disease |
| 01/30/2014 | WO2014018274A1 Compositions comprising chimeric ospa molecules and methods of use thereof |
| 01/30/2014 | WO2014017394A1 Novel iron-zinc binding control factor, and technique for improving iron deficiency tolerance of plant and enhancing iron and zinc accumulation in edible part thereof by controlling expression of novel iron-zinc binding control factor |
| 01/30/2014 | WO2014017106A1 Compositions Comprising RAC Mutants, and Methods of Use Thereof |
| 01/30/2014 | WO2014016737A1 Novel chicken monoclonal antibodies against human phosphorylated tau and uses thereof |
| 01/30/2014 | WO2014016702A2 Humanized forms of monoclonal antibodies to human gnrh receptor |
| 01/30/2014 | WO2014016152A1 Cd147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia |
| 01/30/2014 | WO2014015804A1 Method for preparing homodimer protein mixture by using charge repulsion effect |
| 01/30/2014 | WO2013155526A3 Sortase- modified vhh domains and uses thereof |